| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 05/04/2011 | EP2316836A1 Substituted diazabicycloalkane derivatives as ligands at alpha 7 nicotinic acetylcholine receptors |
| 05/04/2011 | EP2316829A1 Heterocyclic derivatives as modulators of ion channels |
| 05/04/2011 | EP2316820A1 2-aryl-propionamide derivatives useful as bradykinin receptor antagonists and pharmaceutical compositions containing them |
| 05/04/2011 | EP2316531A1 Augmented cognitive training |
| 05/04/2011 | EP2316530A1 Triglycerides, fatty acids, alcohols as CNS modulators |
| 05/04/2011 | EP2316490A2 Methods and compositions for enhanced delivery of bioactive molecules |
| 05/04/2011 | EP2316488A1 Pharmaceutical composition comprising a renin inhibitor, a calcium channel blocker and a diuretic |
| 05/04/2011 | EP2316487A1 Recombinant IL-9 antibodies & uses thereof |
| 05/04/2011 | EP2316466A2 Gram positive bacteria preparations for the treatment of diseases comprising an immune dysregulation |
| 05/04/2011 | EP2316455A1 Pharmaceutical compositions for treating cancer |
| 05/04/2011 | EP2316450A1 Amino-methyl substituted tetracycline compounds |
| 05/04/2011 | EP2316431A1 Solid oral composition comprising a S1P receptor agonist and a sugar alcohol |
| 05/04/2011 | EP2316429A1 Matrix for sustained, invariant and independent release of active compounds |
| 05/04/2011 | EP2316428A1 Matrix for sustained, invariant and independent release of active compounds |
| 05/04/2011 | EP2316426A1 Preparation for the prevention and/or treatment of dementia syndromes |
| 05/04/2011 | EP2315762A2 Fluoro-substituted 3,4-diaryl-4,5-dihydro-1h-pyrazole-1-carboxamidine derivatives having cb1-antagonistic activity |
| 05/04/2011 | EP2315756A2 1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase |
| 05/04/2011 | EP2315742A2 Gabapentin enacarbil salts and processes for their preparation |
| 05/04/2011 | EP2315600A2 Compositions and methods related to sirt1 function |
| 05/04/2011 | EP2315588A1 6-1h-imidazo-quinazoline and quinolines derivatives, new mao inhibitors and imidazoline receptor ligands |
| 05/04/2011 | EP2315585A1 Controlled release treatment of depression |
| 05/04/2011 | EP2315582A2 Probiotic composition useful for dietary augmentation and/or combating disease states and adverse physiological conditions |
| 05/04/2011 | EP2155669B1 New disubstituted phenylpyrrolidines as modulators of cortical catecholaminergic neurotransmission |
| 05/04/2011 | EP2091526B1 Treatment of pervasive developmental disorders |
| 05/04/2011 | EP2044020B1 Crystalline forms of 4- [2- (4-methylphenylsulfanyl) -phenyl]piperidine with combined serotonin and norepinephrine reuptake inhibition for the treatment of neuropathic pain |
| 05/04/2011 | EP2035373B1 Phenyl pyrrole aminoguanidine derivatives |
| 05/04/2011 | EP2011497B1 Phenotropil for the prophylaxis and treatment of hemorrhagic stroke and acute phase of ischemic stroke |
| 05/04/2011 | EP1855661B1 Formulation for aviptadil |
| 05/04/2011 | EP1802372B1 Cgrp receptor antagonists |
| 05/04/2011 | EP1796663B1 Tricyclic heteroaryl piperazines, pyrrolidines and azetidines as serotonin receptor modulators |
| 05/04/2011 | EP1794122B1 3-substituted-5- and 6-aminoalkyl indole-2-carboxylic acid amides and related analogs as inhibitors of casein kinase i |
| 05/04/2011 | EP1551412B1 Pharmaceutical compositions for the treatment of diseases related to neurotrophines |
| 05/04/2011 | EP1494650B1 Pharmaceutical formulation comprising melatonin |
| 05/04/2011 | EP1446100B1 Injectable depot compositions and uses thereof |
| 05/04/2011 | EP1414439B1 Novel pyrroles having hypolipidemic hypocholesteremic activities, process for their preparation and pharmaceutical compositions containing them and their use in medicine |
| 05/04/2011 | EP1353684B1 Use of inhibitors of dipeptidypeptidase iv (ec 3.3.14.5) and aminopeptidase n (ec 3.4.11.2) for the treatment of neurodegeneration induced by ischaemia |
| 05/04/2011 | EP1317448B2 Pyrazole compounds useful as protein kinase inhibitors |
| 05/04/2011 | EP1306429B1 Method of screening ptp zeta activity promoter or inhibitor |
| 05/04/2011 | EP1252156B1 Blockade of voltage dependent sodium channels |
| 05/04/2011 | CN1985901B Chinese medicine composition for promoting blood circulation and dredging collaterals and its preparing method and use |
| 05/04/2011 | CN1943681B A Chinese traditional medicinal composition for treatment of child hypophrenia and its preparation method |
| 05/04/2011 | CN1918131B Novel inhibitors of glutaminyl cyclase |
| 05/04/2011 | CN1899428B Chinese medicine preparation for treating pain and its preparing method |
| 05/04/2011 | CN1863504B Long term drug delivery devices with polyurethane based polymers |
| 05/04/2011 | CN1847229B 2,4,8- trisubstituted-8H- pyridine[2,3-d] pyridine -7-one compound |
| 05/04/2011 | CN1772032B Application of sea-buckthorn fruit oil and sea-buckthorn leaf in preparing medicine for treating depression |
| 05/04/2011 | CN102046639A New classes of GABAA/BzR ligands |
| 05/04/2011 | CN102046633A Substituted spirocyclic cyclohexane derivatives |
| 05/04/2011 | CN102046627A GABAA receptor modulators |
| 05/04/2011 | CN102046625A Bridged heterocyclic compounds and methods of use |
| 05/04/2011 | CN102046624A Tetrahydronaphthyridines and aza derivatives thereof as histamine H3 receptor antagonists |
| 05/04/2011 | CN102046620A Novel benzothiophene oxide derivative and salt thereof |
| 05/04/2011 | CN102046609A Pyrimidine derivative having cell-protecting activity and use thereof |
| 05/04/2011 | CN102046597A (hetero-)aryl cyclohexane derivatives |
| 05/04/2011 | CN102046596A Substituted cyclohexyldiamines |
| 05/04/2011 | CN102046595A Substituted 4-aminocyclohexane derivatives |
| 05/04/2011 | CN102046591A Hydroxymethylcyclohexyl amines |
| 05/04/2011 | CN102046575A Therapeutic agent for alzheimer's disease |
| 05/04/2011 | CN102046240A Novel P2X7R antagonists and their use |
| 05/04/2011 | CN102046201A Inhibitor of analgesic tolerance |
| 05/04/2011 | CN102046171A Transdermal preparation |
| 05/04/2011 | CN102046164A Combination of a nicotinic receptor partial agonist and of an acetylcholinesterase inhibitor, pharmaceutical composition containing same and use thereof in the treatment of cognitive disorders |
| 05/04/2011 | CN102041316A Application of micro ribonucleic acid (miRNA)-219 compound as marker of brain glioma |
| 05/04/2011 | CN102041225A Health-promoting and life-prolonging prepared medicinal liquor |
| 05/04/2011 | CN102041224A Prepared yellow pine healthcare wine |
| 05/04/2011 | CN102041223A Chrysanthemum prepared medicinal wine |
| 05/04/2011 | CN102041222A Medicinal liquor prepared from schisandra berry |
| 05/04/2011 | CN102041108A Biodiesel product made from aleurites montana seeds and preparation method thereof |
| 05/04/2011 | CN102040667A Method for biologically removing protein from sea cucumber polysaccharide |
| 05/04/2011 | CN102040662A Antibodies against human IL-21 receptor and uses therefor |
| 05/04/2011 | CN102040601A 1-N-(1-azabicyalo(2,2,2) octane ether compound and application thereof |
| 05/04/2011 | CN102040600A Substituted 1-azabicyclo (2, 2, 2) octane quaternary ammonium salt and use thereof |
| 05/04/2011 | CN102040599A Pharmaceutical application of bicyclo-(2,2,2) octane pentenyl ester |
| 05/04/2011 | CN102040598A Pharmacy application of 1-aza-bicyclo (2, 2, 2) octane amyl |
| 05/04/2011 | CN102040558A Substituted bicyclo(3,3,1)nonane ether compound and application thereof |
| 05/04/2011 | CN102040556A Optical isomers of indene quinazoline, preparation method and medicinal application thereof |
| 05/04/2011 | CN102040552A 1, 2-di(cyclic group)substituted benzene derivative |
| 05/04/2011 | CN102040550A Inhibitors of cytosolic phospholipase A2 |
| 05/04/2011 | CN102038952A Composition for improving the viability of nerve cells and use of the composition |
| 05/04/2011 | CN102038938A Therapies for chronic inflammatory demyelinating polyneuropathy using interferon-beta |
| 05/04/2011 | CN102038932A Metal-binding compounds and uses therefor |
| 05/04/2011 | CN102038913A Oral preparation for treating cerebral apoplexy and preparation method and application thereof |
| 05/04/2011 | CN102038898A Method for preparing alpinia oxyphylla |
| 05/04/2011 | CN102038874A Quality control method of traditional Chinese medicine preparation |
| 05/04/2011 | CN102038870A Health-care medicinal liquor prepared from tall gastrodia tuber and lucid ganoderma |
| 05/04/2011 | CN102038867A Antialcoholismic composition and preparation method thereof |
| 05/04/2011 | CN102038866A Chinese herb extract for treating neuropathic pain and preparation thereof |
| 05/04/2011 | CN102038862A Medicinal liquor prepared from ginseng and medlar |
| 05/04/2011 | CN102038847A Medicinal liquor prepared from root of red-rooted salvia |
| 05/04/2011 | CN102038828A Kidney-tonifying health-care prepared medicinal liquor |
| 05/04/2011 | CN102038816A External traditional Chinese medicine for drug rehabilitation, and preparation method thereof |
| 05/04/2011 | CN102038804A Drink concentrate (extract)-containing preparation |
| 05/04/2011 | CN102038794A Chinese medicinal foot bath therapy method for treating cerebral apoplexy sequela |
| 05/04/2011 | CN102038791A Refreshing liniment |
| 05/04/2011 | CN102038786A Preparation method of morinda officinalis traditional Chinese medicine |
| 05/04/2011 | CN102038760A Medicated wine prepared from astragalus |
| 05/04/2011 | CN102038731A Original herb of common sowthistle hard capsules |
| 05/04/2011 | CN102038721A Pinus extract and application thereof |
| 05/04/2011 | CN102038710A Method for preparing bee venom injection |
| 05/04/2011 | CN102038706A Drug treatment and rehabilitation Chinese herbal composition |